How Do Stroke and Sleep Apnea Affect Cognition?
WASHINGTON, DC—Patients with stroke and sleep apnea may have worse memory and executive function, compared with... More
Allan Krumholz, MD
Dr. Krumholz, lead author of the AAN/AES guideline on management of first unprovoked seizures, discusses the key points... More
Does Amyloid Accumulation Cause Midlife Cognitive Decline?
Cognitive decline in middle age may not result from β-amyloid deposition, according to a study published online ahead... More
Stroke Survivors May Have Increased Risk of Cancer
NASHVILLE—The annual rate of age-adjusted cancer incidence is higher among patients who have had ischemic stroke,... More
Patients With Wake-Up Stroke May Be Candidates for t-PA
NASHVILLE—Tissue plasminogen activator (t-PA) appears to be safe in the treatment of stroke detected when people wake... More

Consortium of Multiple Sclerosis Centers

INDIANAPOLIS—Self-reported monitoring through an automated telehealth mechanism can provide a valid assessment of disease-modifying therapy (DMT) adherence among patients with multiple sclerosis (MS), according to study findings reported at the 201... More »
 

Consortium of Multiple Sclerosis Centers

INDIANAPOLIS—Although many women with multiple sclerosis (MS) are perimenopausal, the literature contains few data about effective ways to manage these women’s symptoms, according to research presented at the 2015 CMSC Annual Meeting. The topic c... More »
 

Consortium of Multiple Sclerosis Centers

INDIANAPOLIS—Early detection of progressive multifocal leukoencephalopathy (PML) may improve outcomes, according to an update presented at the 2015 Consortium of Multiple Sclerosis (MS) Centers Annual Meeting. When PML results from reversible immun... More »
 

Consortium of Multiple Sclerosis Centers

INDIANAPOLIS—Smoked cannabis may compromise cognitive function in patients with multiple sclerosis (MS), according to an overview presented at the 2015 Consortium of MS Centers Annual Meeting. Evidence does not support the hypothesis that cannabis ... More »
 

Consortium of Multiple Sclerosis Centers

INDIANAPOLIS—A standardized MRI is important for the diagnosis and follow-up of patients with multiple sclerosis (MS). However, acquisition and interpretation of MRI scans may be complicated due to differences in pulse sequence (eg, FLAIR vs PD/T2)... More »
 
Persistently high depressive symptoms are associated with increased stroke risk, according to a study published May 13 in Journal of the American Heart Association. This research included health information from 16,178 men and women age 50 or older w... More »
 

American Academy of Neurology

WASHINGTON, DC—Familial genetic studies suggest that GLUT1 deficiency may be more common among patients with epilepsy than previously understood, according to Ingrid Scheffer, MBBS, PhD, Professor of Pediatric Neurology at the University of Melbour... More »
 

American Academy of Neurology

WASHINGTON, DC—Among patients with Parkinson’s disease, aerobic exercise may improve white matter integrity in the putamen, according to research presented at the 67th Annual Meeting of the American Academy of Neurology. The increased white matte... More »
 

American Academy of Neurology

WASHINGTON, DC—The motor subtype classification of patients with Parkinson’s disease may shift over time, according to research presented at the 67th Annual Meeting of the American Academy of Neurology. Patients primarily shift from a tremor-domi... More »
 

American Academy of Neurology

WASHINGTON, DC—A drug that contains dextromethorphan and quinidine may reduce agitation in patients with Alzheimer’s disease, according to a study described at the 67th Annual Meeting of the American Academy of Neurology. The drug, known as AVP-9... More »
 

American Academy of Neurology

WASHINGTON, DC—Patients taking perampanel may not require routine laboratory monitoring, according to data from three trials presented at the 67th Annual Meeting of the American Academy of Neurology. Those taking the adjunctive seizure treatment sh... More »
 
The concept that biotin, a water-soluble vitamin, could have a beneficial effect on the course of multiple sclerosis (MS) is biologically plausible. Biotin activates acetyl-CoA carboxylase, a potential rate-limiting enzyme in myelin synthesis, and ha... More »
 

American Academy of Neurology

WASHINGTON, DC—Biotin may result in clinical improvement among patients with progressive multiple sclerosis (MS) and decrease the risk of progression, according to a study described at the 67th Annual Meeting of the American Academy of Neurology. T... More »
 

American Academy of Neurology

WASHINGTON, DC—Amifampridine phosphate is a safe and effective symptomatic treatment for patients with Lambert-Eaton myasthenic syndrome (LEMS), according to Phase III data presented at the 67th Annual Meeting of the American Academy of Neurology. ... More »
 
NEW ORLEANS—Psychotic, not physical, symptoms, might be the most distressing aspect of Parkinson’s disease for patients, families, and caregivers, according to an overview presented at the 2015 Annual Meeting of the American Association for Geria... More »
 

American Academy of Neurology

WASHINGTON, DC—Treatment with daclizumab high-yield process (DAC HYP), a first-in-class immunomodulator administered subcutaneously once per month, was significantly more effective on various outcomes in relapsing-remitting multiple sclerosis (MS) ... More »
 
Decreased ability to identify odors may be a marker of acute structural neuropathology resulting from trauma, according to research published online ahead of print March 18 in Neurology. Quantitative identification olfactometry has limited sensitivit... More »
 
A sense of purpose in life may reduce the risk for cerebral infarcts by approximately half, according to data published in the April issue of Stroke. Purpose in life is a psychosocial concept that involves having meaning and being directed toward goa... More »
 

International Stroke Conference

NASHVILLE—Patients who were treated by a new mobile stroke unit had their CT scans read sooner and received thrombolysis more quickly, compared with patients who first were taken to the hospital, according to data presented at the 2015 Internationa... More »
 
Most cerebellar ataxias cannot be cured, but cases that result from metabolic, hereditary, inflammatory, and immune-mediated etiologies can be treated with disease-modifying therapies, according to a review article published online ahead of print Mar... More »
 
The study by Dr. Werhahn et al provides well needed information in a special subgroup of epilepsy patients: the elderly. The elderly are the fastest growing segment of our population. However, despite this fact, the elderly also are the group of epil... More »
 
Antioxidant Therapy May Have Promising Potential in Concussion Treatment A study conducted by investigators at West Virginia University suggests that antioxidants may play a key role in reducing the long-term effects of concussions and could potentia... More »
 

International Stroke Conference

NASHVILLE—Severity of white matter disease is an independent predictor of long-term full recovery in patients with mild acute ischemic stroke, researchers reported at the 2015 International Stroke Conference. Additionally, data indicate that IV t-P... More »
 
The rate of pediatric epilepsy surgery has increased significantly in the United States during the past decade, according to an investigation published in the March issue of Epilepsia. Nevertheless, epilepsy surgery remains an underutilized treatment... More »
 

International Stroke Conference

NASHVILLE—The amount of distal flow in the posterior circulation is a robust predictor of subsequent risk of vertebrobasilar stroke, according to data described at the 2015 International Stroke Conference. “Large-vessel flow measurements represen... More »
 
For patients who have active multiple sclerosis (MS) despite using injectable immunomodulators, switching to the oral immunomodulator fingolimod yields fewer relapses and less disability than does switching to a different injectable immunomodulator, ... More »
 

American Academy of Neurology

Dr. Riley Bove discusses how to counsel patients with multiple sclerosis about issues related to pregnancy.... More »
 

American Academy of Neurology

At the 67th Annual Meeting of the American Academy of Neurology, Dr. Gerard Gioia discusses the return of youth with concussion to cognitive activity and school.... More »
 

American Academy of Neurology

At the 67th Annual Meeting of the American Academy of Neurology, Dr. Stewart Tepper discusses results from the COMPASS trial, a comparative effectiveness trial of intranasal delivery of low-dose sumatriptan for migraine relief.... More »
 

American Academy of Neurology

Dr. Cowan and Dr. Alan Rapoport discuss Headache on the Hill, an annual lobbying event in Washington, DC. Organized by the Alliance for Headache Disorders Advocacy, Headache on the Hill brings health professionals, migraine advocates, and patients to... More »
 

American Epilepsy Society

Dr. Andrew Wilner presents his research about chronic pain among patients with epilepsy.... More »
 
Dr. Ardeshna discusses the unique challenges posed by epilepsy in the rapidly expanding elderly population. ... More »
 
Does amyloid accumulation cause the cognitive decline observed in middle age?... More »
 
An investigator on the ESCAPE trial examines the current evidence for endovascular therapy in acute ischemic stroke.... More »
 
Dr. Cowan examines problems with the treatment of primary headache in the emergency department.... More »
 

Headache Cooperative of the Pacific

At the 2015 HCOP conference, Dr. Tepper describes products in development that target CGRP to treat migraine.... More »
 

MARCH 2015

This supplement is sponsored by Raptor Pharmaceuticals Inc.... More »
 

MARCH 2015

This advertorial is sponsored by Cadwell Laboratories, Inc.... More »